US Patent 11033633 ExPEC glycoconjugate vaccine formulations
Patent 11033633 was granted and assigned to Janssen Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11033633 ExPEC glycoconjugate vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
